Action:
Integration of the Final Federal Rule: Registration Requirements for Narcotic Treatment Programs with Mobile Components into the Licensing Regulations
Action 6152
General Information
| Action Summary |
In June 2021, the federal Drug Enforcement Administration (DEA) published a final rule permitting DEA registrants who are authorized to dispense methadone for opioid use disorder to add a “mobile component” to their existing registrations. The Department of Behavioral Health and Developmental Services (DBDHS) is integrating these federal regulations into the Licensing Regulations due to provider interest in supplying these mobile medication assisted treatment (mobile MAT) services. The integration of the federal rules within the Licensing Regulations shall increase transparency and set administrative expectations for this service. The availability of mobile MAT is expected to help address the opioid crisis in Virginia. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This action will go through the normal Executive Branch Review process.
|
| RIS Project |
Yes [7415] |
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
10070
|
Fast-Track
|
Stage complete. This regulation became effective on 12/05/2024. |
Contact Information
|
Name / Title:
|
Susan H. Puglisi
/
Regulatory Research Specialist
|
|
Address:
|
DBHDS Office of Regulatory Affairs
1220 Bank Street, 4th Floor South
Richmond, VA 23219
|
|
Email Address:
|
susan.puglisi@dbhds.virginia.gov
|
|
Phone:
|
(804)371-8043
FAX: (804)371-4609
TDD: (804)371-8977
|
